EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Case for Automated Segmentation of MRI Data in Neurodegenerative Diseases: Type II GM1 Gangliosidosis

Connor J Lewis iD, Jean M Johnston, Precilla D'Souza iD, Josephine Kolstad, Christopher Zoppo iD, Zeynep Vardar iD, Anna Luisa Kühn iD, Ahmet Peker iD, Zubir S Rentiya, Muhammad H Yousef iD, William A Gahl, Mohammed Salman Shazeeb und 2 weitere

NeuroSci · 03.04.2025 · 6 (2) · 31

DOI: 10.3390/neurosci6020031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NeuroSci, online erschienen am 03.04.2025. Verfasst von Connor J Lewis und 13 weiteren Autor:innen. Beteiligte Einrichtung: Office of the Clinical Director and Medical Genetics Branch, National Human Genome Research Institute, 10 Center Drive, Bethesda, MD 20892, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, Intramural Research Program of the National Human Genome Research Institute, Image Processing & Analysis Core (iPAC) at the University of Massachusetts Chan Medical School.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Volumetric analysis and segmentation of magnetic resonance imaging (MRI) data is an important tool for evaluating neurological disease progression and neurodevelopment. Fully automated segmentation pipelines offer faster and more reproducible results. However, since these analysis pipelines were trained on or run based on atlases consisting of neurotypical controls, it is important to evaluate how accurate these methods are for neurodegenerative diseases. In this study, we compared five fully automated segmentation pipelines, including FSL, Freesurfer, volBrain, SPM12, and SimNIBS, with a manual segmentation process in GM1 gangliosidosis patients and neurotypical controls.

Methods

We analyzed 45 MRI scans from 16 juvenile GM1 gangliosidosis patients, 11 MRI scans from 8 late-infantile GM1 gangliosidosis patients, and 19 MRI scans from 11 neurotypical controls. We compared the results for seven brain structures, including volumes of the total brain, bilateral thalamus, ventricles, bilateral caudate nucleus, bilateral lentiform nucleus, corpus callosum, and cerebellum.

Results

We found volBrain’s vol2Brain pipeline to have the strongest correlations with the manual segmentation process for the whole brain, ventricles, and thalamus. We also found Freesurfer’s recon-all pipeline to have the strongest correlations with the manual segmentation process for the caudate nucleus. For the cerebellum, we found a combination of volBrain’s vol2Brain and SimNIBS’ headreco to have the strongest correlations, depending on the cohort. For the lentiform nucleus, we found a combination of recon-all and FSL’s FIRST to give the strongest correlations, depending on the cohort. Lastly, we found segmentation of the corpus callosum to be highly variable.

Conclusions

Previous studies have considered automated segmentation techniques to be unreliable, particularly in neurodegenerative diseases. However, in our study, we produced results comparable to those obtained with a manual segmentation process. While manual segmentation processes conducted by neuroradiologists remain the gold standard, we present evidence to the capabilities and advantages of using an automated process that includes the ability to segment white matter throughout the brain or analyze large datasets, which pose feasibility issues to fully manual processes. Future investigations should consider the use of artificial intelligence-based segmentation pipelines to determine their accuracy in GM1 gangliosidosis, lysosomal storage disorders, and other neurodegenerative diseases.

Schlagwörter

Stichwörter der Autor:innen

GM1 gangliosidosisMRI segmentationimaging biomarkers

Autor:innen und Institutionen

  • Office of the Clinical Director and Medical Genetics Branch, National Human Genome Research Institute, 10 Center Drive, Bethesda, MD 20892, USA.
  • McLean Hospital, Belmont, MA 02478, USA.
  • Department of Radiology, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.
  • Koç University Hospital, Istanbul 34010, Türkiye.
  • Department of Radiation Oncology & Radiology, University of Virginia, Charlottesville, VA 22903, USA.
  • Department of Perioperative Medicine, National Institutes of Health Clinical Center, 10 Center Drive, Bethesda, MD 20892, USA.

ORCID-Profile: Connor J Lewis, Precilla D'Souza, Christopher Zoppo, Zeynep Vardar, Anna Luisa Kühn, Ahmet Peker, Muhammad H Yousef, Cynthia J Tifft

Förderung

  • Intramural NIH HHS
  • Intramural Research Program of the National Human Genome Research Institute
  • Image Processing & Analysis Core (iPAC) at the University of Massachusetts Chan Medical School

Zitieren

APA

Lewis, C. J., Johnston, J. M., D'Souza, P., Kolstad, J., Zoppo, C., Vardar, Z., Kühn, A. L., Peker, A., Rentiya, Z. S., Yousef, M. H., Gahl, W. A., Shazeeb, M. S., Tifft, C. J., & Acosta, M. T. (2025). A Case for Automated Segmentation of MRI Data in Neurodegenerative Diseases: Type II GM1 Gangliosidosis. NeuroSci, 6(2), 31. https://doi.org/10.3390/neurosci6020031

Vancouver

Lewis CJ, Johnston JM, D'Souza P, Kolstad J, Zoppo C, Vardar Z, et al. A Case for Automated Segmentation of MRI Data in Neurodegenerative Diseases: Type II GM1 Gangliosidosis. NeuroSci. 2025;6(2):31. doi:10.3390/neurosci6020031

BibTeX
@article{Lewis2025,
  author = {Lewis, Connor J and Johnston, Jean M and D'Souza, Precilla and Kolstad, Josephine and Zoppo, Christopher and Vardar, Zeynep and Kühn, Anna Luisa and Peker, Ahmet and Rentiya, Zubir S and Yousef, Muhammad H and Gahl, William A and Shazeeb, Mohammed Salman and Tifft, Cynthia J and Acosta, Maria T},
  title = {A Case for Automated Segmentation of MRI Data in Neurodegenerative Diseases: Type II GM1 Gangliosidosis},
  journal = {NeuroSci},
  year = {2025},
  volume = {6},
  number = {2},
  pages = {31},
  doi = {10.3390/neurosci6020031}
}
Kostenlos starten →